住院急性肾脏病患者肾活检相关并发症分析
基于耶鲁活检队列,2015-2017年159例因急性肾脏病住院行肾活检的患者中,8%需输血,2%需介入干预,7%出现血肿,20%需再影像学检查;女性、较低血小板计数和较高BUN与活检后输血相关。住院患者并发症风险高于既往非住院患者报告。
要点
- 住院AKD患者肾活检后8%需输血,20%需再影像学检查。
- 女性、低血小板计数、高BUN与活检后输血独立相关。
- 住院患者活检并发症风险高于非住院患者,知情同意时应考虑此差异。
核心结论
- 住院急性肾脏病患者肾活检后并发症风险高于既往非住院患者报告,女性、较低血小板计数和较高BUN与输血风险相关。
研究设计与样本
- 回顾性队列研究,使用耶鲁活检队列数据,纳入2015-2017年159例因急性肾脏病住院行肾活检的患者。
主要发现
- 12例(8%;95%CI 5%至15%)需输血,3例(2%;95%CI 1%至5%)需介入干预,11例(7%;95%CI 4%至12%)出现血肿,31例(20%;95%CI 14%至26%)需再影像学检查。
- 住院期间4例(3%;95%CI 1%至6%)死亡,均与活检无关。
- 单变量和多变量分析显示女性、较低血小板计数和较高BUN与活检后输血相关。
- 单变量分析中操作者为受训者和较大针径与输血相关,但多变量分析中不显著。
- 非住院患者输血率低于住院患者,但住院患者活检前血红蛋白更低且活检后监测更密切。
临床怎么用
- 对住院急性肾脏病患者行肾活检前,应评估血小板计数、BUN和性别等风险因素,并加强活检后监测。
局限性
- 研究为单中心队列,样本量有限,部分并发症事件数较少,可能影响风险因素分析的稳定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients are informed of the risk of kidney biopsy-related complications using data from nonhospitalized patients, which may underestimate the risk for hospitalized patients. We evaluated the rate and risk factors of kidney biopsy-related complications in hospitalized patients with acute kidney disease (AKD) to better estimate the risk in this population. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We used data from the Yale biopsy cohort to evaluate rates of kidney biopsy-related complications including adjudicated procedure-related bleeding requiring blood transfusions or angiographic interventions, medium- or large-sized hematomas, reimaging after biopsy including abdominal ultrasonography or computed tomography, and death in hospitalized patients with AKD (including AKI). We evaluated univariable and multivariable association of risk factors with transfusions. We compared rates of complications between hospitalized and nonhospitalized patients. RESULTS: Between 2015 and 2017, 159 hospitalized patients underwent a kidney biopsy for AKD evaluation, of which 80 (51%) had stage 1 AKI, 42 (27%) had stage 2 (or higher) AKI, and 27 (17%) had AKD (without AKI). Of these, 12 (8%; 95% confidence interval [95% CI], 5% to 15%) required a transfusion, three (2%; 95% CI, 1% to 5%) required an intervention, 11 (7%; 95% CI, 4% to 12%) had hematoma, and 31 (20%; 95% CI, 14% to 26%) required reimaging after biopsy. Of the four (3%; 95% CI, 1% to 6%) deaths during hospitalization, none were related to the biopsy. Female sex, lower platelet count, and higher BUN were associated with postbiopsy transfusions on univariable and multivariable analyses. Trainee as proceduralist and larger needle gauge were associated with transfusions in univariable, but not multivariable, analysis. Nonhospitalized patients had lower rates of transfusion than hospitalized patients, although the latter also had lower prebiopsy hemoglobin and greater surveillance after biopsy. CONCLUSIONS: Hospitalized patients experience higher risk of postbiopsy complications than previously reported and several factors, such as lower platelet count, female sex, and higher BUN, are associated with this risk.
引用
- Moledina DG, Luciano RL, Kukova L, et al. Kidney Biopsy-Related Complications in Hospitalized Patients with Acute Kidney Disease. Clin J Am Soc Nephrol. 2018. PMID: 30348813. doi:10.2215/CJN.04910418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。